Health Novo Nordisk Shares Plunge as Heart Drug Trial Fails to Meet Key Goal August 1, 2026 Novo Nordisk faced a sharp selloff on Friday after the Danish pharmaceutical giant announced that its experimental heart drug ziltivekimab failed to achieve its primary goal in a late-stage clinical…
Markets Teva Stock Trades 23.7% Below Fair Value After Sharp Pullback June 22, 2026 Teva Pharmaceutical Industries captures renewed investor attention after a recent share price pullback, with the stock closing at $31.48. Market participants now assess whether the current valuation aligns with the…